Background: We have assessed the impact of introducing robotics for a stage 1b
shown by one group to lower the length of hospital stay with no impact on complication rates or costs. 3 It has been demonstrated that the introduction of robotics for endometrial cancer surgery reduces complications and costs by lowering the proportion of operations performed open. 4 To date, no study has assessed the financial and clinical effect of introducing robotics for cervical cancer into a UK National Health Service institution.
We have compared the financial and clinical outcomes in three groups of women having radical hysterectomies for stage 1bi cervical cancer and examined how the introduction of robotics has affected the service in terms of clinical and financial outcomes.
| MATERIALS AND METHODS
A clinical and financial audit was undertaken for radical hysterectomy for stage 1bi cervical cancer from the period of 1 April 2010 to 31
December 2017. Robotic surgery was introduced into the service for cervical cancer on 4 April 2013, and comparisons were made for operations performed before and after this date.
Clinical data for patients receiving primary surgery for stage 1bi cervical cancer were obtained from a prospectively collected surgical database and cross-referenced against the hospital's electronic patient record (EPR). The EPR system contained operative and clinical notes.
In addition, it contained a prospective and systematically collected pre-operative anesthetic assessment, microbiological records, blood transfusion records, histopathology, radiology, cytopathology, hematology, and biochemistry results. All clinical documentation for patients were reviewed. Clavien-Dindo 5 grade II complications and above were collected for 30 days following surgery.
Costs were assessed independent of clinicians by the hospital's finance department using a system called "Patient Level Inpatient
Costs" (PLIC) that has been described in detail previously. 4, 6 In summary, costs and over-heads were allocated into one of nine categories.
They included costs for wards, high-dependency care, medical staffing, theatres, drugs and pharmacy, blood products, imaging, pathology, and rehabilitation therapy. The exact allocation of different costs and overheads into each of these categories is detailed in another publication. 4 Expenses are presented twice, with and without amortization costs for both the robot and integrated operating theatre (OR1TM Storz, Stuttgart, Germany) for SIL. For RS, £598.02 was added per case, and an additional £25.80 per case was added for SIL operations. No amortization costs were added for OS. These figures were based on the actual cost paid for each system with depreciation calculated over a 10-year period and the number of cases performed annually.
All operations included a radical hysterectomy and removal of the fallopian tubes. Removal of the ovaries was dependent on age and menopausal status and was discussed with patients pre-operatively.
The surgery routinely performed was a Piver-Rutledge type III (Querleu-Morrow type C1) hysterectomy with preservation of the inferior hypogastric nerve plexus. The uterine arteries were divided at their source, and the rectum and bladder were mobilized. Separate pedicles were ligated at the deep and superficial utero-sacral ligaments, cardinal ligaments, and ureteric tunnels using bipolar diathermy (SIL and RS) or sutures (OS). Nerve fibers were preserved by mobilizing them laterally after identifying the inferior hypogastric plexus superior to the sacrum.
Further fibers were preserved by entering Okobayashi's space lateral to the utero-sacral ligaments and inferior to the ureter. A systematic pelvic lymphadenectomy was performed dissecting the obturator nodes, internal iliac nodes, and external iliac nodes from the circumflex iliac vessel to the bifurcation of the common iliac artery.
Robotic cases were performed with three 8-mm operating arms, a 12-mm umbilical port for the camera, and a 10-mm assistant's port with side docking when using the da Vinci S robot (Intuitive Surgery Inc., CA, USA). An 8-mm port was used instead of the 12-mm umbilical port when using the da Vinci Xi robot (Intuitive Surgery Inc., CA, USA) with side docking. Lymph nodes were normally placed in a bag prior to retrieval. Laparoscopic cases were performed with two 12-mm ports centrally and two 5-mm ports laterally. In two cases, a 5-mm port was placed in the suprapubic position instead of a 12-mm port. In the majority of cases, the main specimen was retrieved through the vagina, and lymph nodes were placed in bags and retrieved through the supra-pubic Dichotomous data were analyzed using the Fisher's exact test.
Continuous data were assessed for normality using the Shapiro-Wilks test. As most series were significantly different from a normal distribution, they were presented as medians with a range and comparisons made using the Mann-Whitney test. The project had ethical approval as a service evaluation project from the Royal Marsden Committee on Clinical Research (SE314).
FIGURE 1
The proportion of radical hysterectomies performed by each route by year The demographics, comorbidities, and histology before and after the introduction of robotics are presented in Table 1 . There was a significant reduction in the length of stay from a median of 6 days (range 3-39) to 3 days (range 1-15) after the introduction of RS (P < 0.0001) ( Table 1) .
Furthermore, there was a significant reduction in blood loss from a median of 500 mL (range 50-2500 mL) before the introduction of robotics to 100 mL (range 100-2000 mL) afterwards (P < 0.0001). This was mirrored by a significant reduction in the median drop in hemoglobin from 28 g/L (range 6-61 g/L) before robotics to 20 g/L (range 2-42 g/L) afterwards Some patients had more than one co-morbidity.
b Only 80 of the 90 patients had a complete lymphadenectomy at the time of the radical hysterectomy. One only consented to a sentinel lymph node dissection. Three patients had already had chemotherapy or radiotherapy and were having surgery for either residual disease or a neuroendocrine tumour. Five patients had already had a laparoscopic lymphadenectomy at the time of their examination under anaesthetic and were lymph node negative. One patient had previous spinal surgery complicated by a massive retroperitoneal haemorrhage, and it was decided to omit the lymphanadectomy secondary to the previous complication and MRI findings. For the lymph node count, only the 80 patients were included. To determine the positivity rate, all patients who had a lymph node dissection (either a sentinel or at a previous sitting) were included as the denominator. Estimated blood loss (mL)-median (range) 700 (50 to 2500) 100 (100 to 1000) 100 (100 to 250) RS vs OS: P < 0.0001, (600: 400 to 1070) RS vs SIL: P = 0.0142, (0: 0 to 100) SIL vs OS: P < 0.0001, (500: 300 to 950) (Continues) ( Table 1 ). There was a reduction in the overall complication rate from 67.6% (25/37) prior to robotics to 45.3% (24/53) afterwards (P = 0.0493) ( Table 2 ). This was most marked by a reduction in the blood transfusion rates from 43.2% (16/35) to 11.3% (6/53) (P = 0.0007) ( Table 2 ).
The demographics, comorbidities, and histology for patients by each radical hysterectomy route are detailed in Table 3 . More patients in the robotic arm had a recorded medical comorbidity than those in the SIL group (68.8% vs 32.0%, P = 0.0072) ( Table 3 ). The duration of surgery was longer in the SIL arm compared with RS which in turn was longer than OS (Table 3 ). The length of hospital stay was also longer in the OS arm than in SIL or RS and longer in the SIL arm compared with RS (Table 3) . The blood loss and drop in hemoglobin were greatest in the OS compared with SIL and RS (Table 3 ). There were further reductions in the post-operative drop in hemoglobin in the SIL arm compared with RS (Table 3 (Table 4 ).
There was no difference in total costs before and after the introduction of robotics, but there were savings without amortization after the introduction of robotics even though the theatre costs were higher (Table 5) . Reductions in cost were demonstrated for ward costs, pharmacy charges, imaging costs, rehabilitation, and high dependency care outgoings (Table 5) . However, the cost of amortization cancelled out any savings demonstrated in the PLIC categories. The breakdown of costs for each PLIC sub-category and each arm of the analysis is shown in Table 6 . Robotic surgery was associated with lower ward and high dependency expenses but higher theatre costs compared with OS and SIL (Table 6 ). Overall, no differences could be demonstrated between the cost of surgery by either route (Table 6 ). This was true whether or not amortization was included in the calculations (Table 6 ).
| DISCUSSION
This study demonstrates similar costs before and after the introduction of robotics for radical hysterectomy for cervical cancer. Furthermore, we have shown some advantages for RS over SIL and OS in terms of length of stay, duration of operation, blood loss, lymph node count, and complications.
Some studies have compared just the routes of surgery. 3, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] This study also reports on the impact to a whole service and therefore takes into account the differences in the proportion of patients receiving each route of surgery after robotics are introduced, the hypothesis being that a reduction in the proportion of women having OS would impact on costs and complications. As an observational study, the comparisons do not take into account the extrinsic differences before Cost analyses can take into account many aspects of the expense of health care. This study looked at the institutional costs for a surgical procedure, which were assessed independently by the hospital's finance department. It did not take into account the costs of subsequent treatment for recurrence, as this is unknown. Furthermore, the societal costs are not assessed in this study. In this study, the costs were no different between each route, and this is consistent with the most recent study that also looked at this outcome. b Only 80 of the 90 patients had a complete lymphadenectomy at the time of the radical hysterectomy. One consented to a sentinel lymph node dissection only. Three patients had already had chemotherapy or radiotherapy and were having surgery for either residual disease or a neuroendocrine tumour. Five patients had already had a laparoscopic lymphadenectomy at the time of their examination under anaesthetic and were lymph node negative. One patient had previous spinal surgery complicated by a massive retroperitoneal haemorrhage, and it was decided to omit the lymphanadectomy secondary to the previous complication and MRI findings. For the lymph node count, only the 80 patients were included. To determine the positivity rate, all patients who had a lymph node dissection (either a sentinel or at a previous sitting) were included as the denominator.
Abbreviations: NA, not applicable; ns, not significant; OS, open surgery; RS, robotic surgery; SIL, straight instrument laparoscopy.
However, one previous study found the robotic approach to be more expensive 10 while another reported similar costs compared with OS once a surgeon had experience of over 30 cases. 22 Although many have suggested that introducing robotics might increase the cost of surgery 23 as with endometrial cancer, this hypothesis is not substantiated when comparing a service before and after robotics are introduced. 4, 24, 25 Comparisons between each individual route, although valuable, distract from the cost evaluation of how finances change with the introduction of robotics, which is what institutions experience in reality. This study has demonstrated improvements in blood loss and blood transfusions, complications, and days stay in hospital with the introduction of a robotic service into an institution. Other studies also demonstrate this, 1 but the transfusion rate in the open arm of this series is higher than some other reports and might be a confounding factor.
For endometrial cancer, a reduction in the number of conversions to laparotomy has been demonstrated. 23 In this study, a lower conversion rate has not been shown possibly due to the lower number of comorbidities in patients with cervical cancer compared with endometrial neoplasias. It is not clear why there was a shorter hospital stay for the RS patients compared with those who had SIL, but this may be due to the reduced operative time and lower complications in the robotic arm. The same reasons may explain the differences in imaging costs.
In this study, there were more recurrences in the OS arm compared with SIL and RS although a formal survival analysis was not performed. This has become a topic of interest following recently published data. 26, 27 A formal survival analysis between the groups would not have been valid as it was not the purpose of the study and the outcomes would have been affected by the length of follow-up in each arm.
| CONCLUSION
Our data show that the introduction of robotics into the cervical cancer service in our institution was associated with a shorter hospital stay, less complications, and similar costs. There was a significant reduction in resource to OS with the availability of the robot in out institution.
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